The emergence of carbapenem-resistant Escherichia coli (E coli) is a serious global health threat, but little is known about carbapenemase-producing E coli in Daejeon, South Korea. The aim of this study was to investigate characteristics of thirteen carbapenem-resistant E coli isolates in a tertiary hospital.
| INTRODUC TI ON
The Enterobacteriaceae family are leading causes of infections, such as urinary tract infections, hospital-and healthcare-associated pneumonia, and bloodstream infections. 1 Carbapenems that exhibit broad antibacterial activity among beta-lactams are used as effective antibiotics against Enterobacteriaceae-producing extended-spectrum beta-lactamases (ESBL) and plasmidic AmpC (pAmpC). 2 However, as the emergence of carbapenemase-producing Enterobacteriaceae (CPE) is increasingly reported worldwide, bacterial resistance to antibiotics has become a major source of concern for public health in recent years. [3] [4] [5] [6] According to the report of the European Survey on carbapenemase-producing Enterobacteriaceae (EuSCAPE), 19% (77/402) of E coli clinical isolates not susceptible to carbapenem, are carbapenemase producers 7 (eg, KPC, NDM, VIM, or OXA-48-like). Carbapenemases mainly belong to Ambler classes A, B, and D of beta-lactamase.
Among them, New Delhi metallo-beta-lactamase (NDM) belongs to Ambler class B and can hydrolyze almost all beta-lactam antibiotics, including penicillins, cephalosporins, and carbapenems, except monobactams, such as aztreonam. 8, 9 Since NDM-1 producing Klebsiella pneumonia isolates were initially described in 2008, 9 to date, 21 NDM subtype variants have been reported worldwide. 10 The NDM subtypes contain one to five amino-acid substitutions that confer different levels of hydrolyzing activity against carbapenems and other β-lactam substrates. 3 Among NDM variants, the first NDM-5 was identified in 2011 from a multidrug-resistant E coli ST648 isolate in the United Kingdom, from a patient previously hospitalized in India, and differed from NDM-1 with two amino acid substitutions at positions 88 (Val → Leu) and 54 (Met → Leu). 11 In South Korea, the bla NDM-5 gene was first detected in 2015, in Klebsiella pneumoniae clinical isolates co-producing oxacillinase 181, 12 and has been reported intermittently since then. However, an outbreak of NDM-5-producing isolates, especially E coli ST 361, has not yet been described.
In this study, we report an outbreak of NDM-5-producing E coli in a tertiary hospital in South Korea and characterize the molecular epidemiology and antibiotic resistance profiles of the isolates.
| MATERIAL S AND ME THODS

| Bacterial strains
Chungnam National University Hospital is a 1300-bed tertiary care hospital located in the Daejeon of South Korea, a city of about 1 490 000 residents. Prior to this outbreak, carbapenem-resistant E coli isolates were rarely detected and no case involving carbapenemase-producing E coli had been detected in this hospital. CR-ECO1, which is resistant to carbapenem, including ertapenem and imipenem, was isolated from a urine specimen, obtained from a patient in the neurosurgery ward on October 25, 2017. On October 31, 2017, another carbapenem-resistant CR-ECO2 was isolated from a urine sample of a patient hospitalized in the same ward, within the same period. Until January 23, 2018, a total of thirteen non-duplicate carbapenem-resistant E coli isolates were collected in the hospital. The identification of isolates was performed using the VITEK 2 ID-GNB cards (bioMérieux SA) according to the manufacturer instructions. The modified Hodge test, using ertapenem disks and Carba NP (bioMérieux SA), was conducted to confirm the phenotypic identification of carbapenemase production. 13 Both E coli ATCC 25922 and Pseudomonas aeruginosa ATCC 27853 were used as quality control strains for antimicrobial susceptibility testing. Salmonella enterica serovar Braenderup strain H9812 (ATCC BAA 664) was used as a reference marker for pulsedfield gel electrophoresis (PFGE). The clinical data for each patient were retrospectively reviewed. with CLSI guidelines. 15 Antimicrobial susceptibility to three drugs (ampicillin, cefazolin, and aztreonam) was evaluated using the disk diffusion method on MH agar (Difco Laboratories) in accordance with CLSI guidelines. 15 The MICs for colistin and tigecycline were assessed by the broth microdilution method with MH broth (Difco Laboratories) in accordance with the recommendations of the joint CLSI-EUCAST (2016) 16 and European Committee on Antimicrobial Susceptibility Testing (EUCAST) criteria. 17 
| Antimicrobial susceptibility testing
| Resistance gene detection
Bacterial DNA was extracted using an ExiPrep Dx Bacteria Genomic DNA Kit (BIONEER) according to the manufacturer instructions.
The carbapenemase genes (bla NDM , bla IMP , bla VIM , bla KPC , bla OXA-48-like, bla GES , and bla OXA-181 ) were detected by PCR and direct sequencing was carried out for subtyping. 18 The presence of other resistance ribosomal methyltransferases (armA, rmtA, rmtB, and rmtC) 19, 20 was detected by PCR with gene-specific primers. The amplicons were determined by DNA sequencing. The primers for the PCR are shown in Table 1 . recA for E coli 22 and the sequences were compared in the MLST database, so that allelic numbers and sequence types (STs) could be determined. 3 The allelic profiles and STs were assigned using an online database (http://mlst.warwi ck.ac.uk/mlst/dbs/Ecoli ).
TA B L E 1 The primers used to detect the resistance genes
| RE SULTS
| Clinical characteristics of the Escherichia coli isolates
All thirteen carbapenem-resistant E coli isolates showed positive phenotypic screening results for both the Modified Hodge test and the Carba-NP test. These isolates were obtained from stool (n = 6), urine (n = 5), bile fluid (n = 1), and pus (n = 1) from hospitalized patients aged from 46 to 83, with mean age of 69 years ( Table 2 ). The stool samples were obtained using rectal swabs from patients admitted to an intensive care unit for CPE screening test. The outbreak timeline on the admission date and date of isolation of each patient is shown in Figure 1. 
| Antibiotic resistance profile and distribution of resistant genes
All thirteen E coli isolates harbored bla NDM-5 gene and were resistant to carbapenem (ertapenem and imipenem), ampicillin, piperacillin/tazobactam, and cephalosporins (cefazolin, cefepime, cefotaxime, and ceftazidime; Table 3 ). These isolates were also resistant to ciprofloxacin (92.3%, 12/13), chloramphenicol (92.3%, 12/13), tigecycline (76.9%, 10/13), gentamicin (15.4%, 2/13), and trimethoprim/sulfamethoxazole (7.7%, 1/13). Two isolates out of thirteen were resistant to aztreonam (15.4%, 2/13). All strains remained susceptible to colistin and amikacin.
In addition to bla NDM-5 , 11/13 strains harbored the qepA gene ( Figure 2 ).
The bla TEM-1 was also detected in 23.1% (3/13). In particular, CR-ECO13
isolates also co-harbored bla CMY-2 , bla CTX-M-15 , and aac(6)-Ib-cr genes, as well as bla TEM-1 . Other resistant genes that were evaluated, such as qnrA, qnrB, qnrS, armA, rmtA, rmtB, and rmtC, were not detected.
| Molecular epidemiology by MLST & PFGE
Three distinct MLST STs were observed among the thirteen isolates:
ST361 with allelic profile 10-99-5-91-8-7-2 (11/13, 84.6%), ST12 (1/13, 7.7%), and ST410 (1/13, 7.7%). Moreover, three distinct PFGE patterns (PFGE types A-C) were observed among these thirteen isolates: type A (n = 11), type B (n = 1), and type C (n = 1; Figure 1 ). Comparison of these results showed that all PFGE type A isolates corresponded to ST361, and the type B and C isolates corresponded to ST12 and ST410, respectively.
| D ISCUSS I ON
In this study, we reported and characterized an outbreak caused by shows that E coli is the largest (14/18, 77.8%) and among them, ST 101 accounted for 77.8% (9/14), followed by ST362, ST361, ST162, ST90, and ST88 each accounted for 7. 1% (1/14) . The E coli ST361 harboring bla NDM-5 only accounted for 7.1% (1/14) and did not belong to the most common clones, such as ST101, in South Korea. Therefore, this is the first outbreak report involving NDM-5-producing E coli ST361.
Here, the NDM-5-producing E coli ST361 strains showed high levels of multidrug resistance to carbapenem (ertapenem and imipenem), ampicillin, piperacillin/tazobactam, cephalosporins (cefazolin, cefepime, cefotaxime, and ceftazidime), ciprofloxacin, and chloramphenicol. Among the plasmid-mediated quinolone resistance genes, the co-harbored qepA genes encoding fluoroquinolone efflux pumps could partially contribute to the high rate of ciprofloxacin-resistance. 23 All ST361 strains were susceptible to amikacin, colistin, and trimethoprim/sulfamethoxazole, which mean they are treatment options with potent activity against these pathogens. A few cases of NDM-5-producing E coli ST361 have also been reported in China 24, 25 and Nepal. 26 The bla NDM-5-carrying E coli ST361 that was isolated in Henan, China, showed resistance to sulfamethoxazole and co-harbored various resistance genes such as bla CTX-M-15 , bla TEM-1 , aac(6)-Ib-cr, and qnrs. 25 Additionally, the bla NDM-5 -carrying E coli ST361 that was isolated in Zhejiang province, China carried bla CMY-42 and bla TEM-1B via an IncX3 type plasmid. 24 However, resistance genes such as ESBLs, ampC genes, 16s ribosomal methyltransferases, and quinolone resistance genes, except for qepA, were not detected in NDM-5-producing E coli ST361 in this study.
The CR-ECO 13 isolate, which is E coli ST410, is an extensively drug-resistant strain, resistant to almost all antibiotics except for amikacin and colistin. This strain co-harbored bla CTX-M-15 , bla CMY-2 , and bla TEM-1 , which encodes an ESBL, conferring resistance to aztreonam and aac(6')-Ib-cr, which mediates high-level resistance to aminoglycosides and fluoroquinolones. Escherichia coli ST410 has been reported worldwide as a potential high-risk pathogen associated with resistance to fluoroquinolones, third generation cephalosporins, and carbapenems. 27 Although ST410 is not a main strain of this outbreak, it poses a significant public health risk. These findings suggest that strict infection control is essential to prevent a dissemination of these high-risk clones. The E coli ST12 (CR-ECO 7) was susceptible to various antimicrobial agents (eg, aztreonam, gentamicin, amikacin, ciprofloxacin, trimethoprim/sulfamethoxazole, chloramphenicol, and colistin) and negative for other resistant genes tested, except for bla .
We carried out retrospective investigation with limited patient in- Considering that E coli is one of the major causes of communityacquired infections, and the spread of these strains is possible not only in the hospital, but also in the surrounding environment, the severity of dissemination of E coli carrying the bla NDM-5 gene will be even greater. 2 In conclusion, the rapid dissemination of NDM-5-producing E coli emphasizes that stringent infection control measures and active surveillance play important roles to prevent the spread of these pathogens.
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O RCI D
F I G U R E 2 Dendrogram based on pulsed-field gel electrophoresis patterns, multilocus sequence typing, antibiogram, and distribution of resistance genes of thirteen NDM-5-producing Escherichia coli isolates. The red and blue squares indicate resistance and susceptibility to each antibiotic, respectively
